According to a BBC article, a new vaccine against skin cancer has been developed by scientists in Argentina. The results of tests carried out with animals have been positive, so the vaccine has entered the human trial phase and is being applied to patients with melanoma, one of the most aggressive types of skin cancer.
During the next 4 years, the last stage of trials will be carried out on patients, of a vaccine with dendritic cells that have the characteristic of phagocytizing tumor cells, according to Dr. José Mordoh, director of the team of researchers of the National Council for Scientific and Technical Research and the Fundación Instituto Leloir of Argentina. Scientists hope in the immediate future to be able to apply this new vaccine against melanoma to other types of cancer.
In the words of the executive director of the Sales Foundation, the results of the tests carried out on animals have been "spectacular". 80% of vaccinated mice were cured, while in 100% of diseased mice that were not vaccinated, melanoma took hold.
The results of this new advance in medicine have been published in The Journal of Immunology.